C

Pro-Dex, Inc. PDEX

$71.08 -$0.54-0.75% NASDAQ
Recommendation
Dividend Power Score
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
--
52-Week Range
P/E (TTM)
EPS (TTM)
Access our Premium Ratings
Get Access

Rating

Reward
Risk

Rating Factors

Growth Index
Efficiency Index
Solvency Index
Total Return Index
Volatility Index
Dividend Yield Index

Company Overview

Pro-Dex, Inc. (NASDAQ: PDEX) is a U.S.-based medical technology and precision manufacturing company that designs, develops, and manufactures powered surgical instruments and related components for medical device original equipment manufacturers (OEMs). The company primarily operates within the medical device manufacturing and precision engineering industries, with a focus on powered rotary drive systems, handpieces, and motion-control technologies used in surgical and dental procedures. Its business model centers on long-term OEM relationships in which Pro-Dex provides both engineering support and contract manufacturing services for highly specialized medical instruments.

The company’s principal revenue drivers include sales of powered surgical instruments, micro motors, and precision-engineered components used in orthopedic, cranial, thoracic, and dental applications. Pro-Dex is positioned as a niche supplier capable of producing highly regulated, precision medical products that require complex engineering and manufacturing expertise. Founded in 1978 and headquartered in Irvine, California, the company evolved from a broader industrial technology business into a specialized medical device manufacturing enterprise through strategic operational focus and targeted acquisitions. Public filings and company disclosures indicate that medical device manufacturing now represents the overwhelming majority of revenue and strategic focus.

Data compiled by narrative technology. May contain errors.
Sector

Income Statement

Total Revenue (TTM)
EBITDA (TTM)
EBIT (TTM)
Net Income (TTM)

Balance Sheet

Total Assets (Q)
Total Debt (Q)
Total Liabilities (Q)
Book Value Per Share (Q)

Cash Flow

Cash from Operations (TTM)
Cash from Investing (TTM)
Cash from Financing (TTM)
Net Change in Cash (TTM)

Filings

Filing Date
Thursday, September 3, 2026
Period Date
Tuesday, June 30, 2026
Next Filing
Week of Oct 26 and 30 (est)

Price History

Loading...
52-Week Range89% of range
Low
$23.47
Current
$71.08
High
$77.00
Beta
7-Day Total Return
30-Day Total Return
60-Day Total Return
90-Day Total Return
Year to Date Total Return
1-Year Total Return
2-Year Total Return
3-Year Total Return
5-Year Total Return
52-week Low
52-week High

Valuation

Market Cap
Enterprise Value
Price/Sales (TTM)
Price/Book (Q)

Dividends and Shares

Shares Outstanding
Dividend Per Share (Most Recent)
--
Dividend Per Share (TTM)
--

Corporate Info

Phone Number
949 769 3200
Address
2361 McGaw Avenue
Irvine, CA 92614
Country
Year Founded

Headlines

9/18/2026 - Zacks Investment Research